Rezultati pretraživanja
  1. We are a forward-thinking, mid-sized contract research organization, offering companies of all sizes a proven, flexible approach to early , from lead candidate selection to proof of concept

  2. prije 2 sata

    Our CSO, Gareth Jenkins, is attending ’s in Glasgow. Be sure to say hello to him at the event and find out about our use of transformational technology for more efficient . Get in touch to arrange a meeting here:

  3. Join us and make your expertise researches spread around the world. Be a part of Scheduled during June 22-23, 2020 in Zurich. antibiotics@annualmeetings.net Link:

  4. prije 3 sata

    New development project? Find out how services can help you on your journey. Drop by Booth A68-A70 at

  5. Our Rachna Malik and Dr. Ashish Indani would be speaking at Medical Devices Conference in . At the conference, they will discuss the various strategies for revolution. More on:

  6. Tomorrow we will be set up at the 4th Drug Development Summit in London! If you at the summit, don’t miss your chance to listen to our Director of Microbiology Jeff Heiser at 10 am!

  7. prije 21 sat

    Health status & risk of disease directly correlate to the human . Now, we can understand the mechanism linking microbiota to health. Insights gleaned from multiomic studies like this are fueling today’s & disease risk programs.

  8. prije 21 sat

    Discover our Protein LC-MS/MS and Immunogenicity centres of excellence

  9. prije 21 sat

    This World Cancer Day, we recognise that our commitment to act will lead to powerful progress in reducing the global impact of cancer. Together we can win the battle against

  10. prije 23 sata

    is beginning to transform the historically tortuous and expensive process of bringing a new drug to the clinic.

  11. prije 24 sata

    We're excited to join for the Biomarker Series Conference on our home turf of Manchester! Swing by Booth 1 to discuss how we can accelerate your , or ask us where our favourite bars are 🍸

  12. prije 24 sata

    we want to raise awareness of the lack of kinder and more effective treatments for . We need to a different model to help meet the needs of children. Read more about our projects

  13. 4. velj

    We are delighted to have Susan Welsh, Chief Safety Officer, on board as Chairperson and Moderator for our 21st 2020

  14. 4. velj

    With our in , we won't give up the fight for better patient outcomes and the future of a cancer-free world

  15. 4. velj
  16. 3. velj

    Outsourcing in the Cell & Gene Therapy Space - Steven Anderson PhD, CSO Covance, explains how specialized and coordinated capabilities aim to accelerate and reduce risk for sponsors.

  17. 3. velj

    Bristol-Myers withdraws Opdivo/Yervoy lung cancer EU application — but others are incoming – Endpoints News

  18. Meet , CEO of CILcare, at the LSX World Congress in London on February 4-5! She will give a presentation about CILcare tomorrow at 4:30 PM during the Biotech Inv€€$table Showcase.

  19. 3. velj

    Global Cancer Drug Market is expected to reach $176.509 million by 2025

  20. 31. sij

    Speaking solely as mom of a kid w/ , I’m grateful for the & thank all who joined & ran these . That said, a product that still requires allergen avoidance, 100% avail of epi, & can itself cause anaphylaxis is a 👎🏼 for me as a mom. 😞

    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.